MedTrace Logo

Platelet-rich Plasma Versus Corticosteroid Injection for the Treatment of Femoroacetabular Impingement

NCT02920177 · Status: TERMINATED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 4

Last updated 2020-04-03

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to compare the clinical response of intra-articular platelet rich plasma (PRP) versus corticosteroid injection in patients affected by femoroacetabular impingement (FAI).

Conditions

  • Femoroacetabular Impingement

Interventions

DRUG

platelet-rich plasma injection

platelet-rich plasma injection

DRUG

Kenalog 10 MG/ML Injectable Suspension

4 mL corticosteroid injection

Sponsors & Collaborators

Principal Investigators

  • Tariq M Awan, DO · University of Michigan

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-08-01
Primary Completion
2018-08-10
Completion
2018-08-10

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02920177 on ClinicalTrials.gov